Statistics for Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy
Total visits
| views | |
|---|---|
| Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy | 1 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Kashyap2024Targeting-CCBY.pdf | 18 |
| java.util.UUID:f898dfee-604b-4f4c-9aff-a0c9e3a6c72f | 17 |
| java.util.UUID:5f51c21a-f371-455b-b15e-974f67840da7 | 16 |
| java.util.UUID:9da6078a-9633-43a1-8843-21b8aba8ae9b | 7 |
Top country views
| views | |
|---|---|
| United States | 1 |
Top city views
| views | |
|---|---|
| Indianapolis | 1 |